| Dr Robert Frank Werkman, MD | |
|
1421 Fishburn Rd, Hershey, PA 17033-9795 | |
| (717) 533-2224 | |
| (717) 533-2164 |
| Full Name | Dr Robert Frank Werkman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 1421 Fishburn Rd, Hershey, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245237957 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD 070313L (Pennsylvania) | Primary |
| Entity Name | Gastroenterology Associates Of Central Pennsylvania, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356303440 PECOS PAC ID: 8820053572 Enrollment ID: O20041123000010 |
News Archive
The American Association for Cancer Research (AACR) released findings today from one of the largest studies to date on passive smoking and breast cancer in women conducted by the Northern California Cancer Center (NCCC).
Cancer researchers at Princess Margaret Hospital (PMH) have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
Responding to continued debate over PSA screening, and today's American Cancer Society statement, the Prostate Cancer Foundation reiterated its position that PSA screening remains a valuable tool, in combination with other tools, for identifying potential prostate disease, including cancer.
LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced it has entered into an agreement providing for an Equity Line Facility (ELF) with Dutchess Opportunity Cayman Fund Ltd., a fund managed by Dutchess Capital Management, II LLC. Under the terms of the ELF, Dutchess has committed to provide up to $10 million of capital during the next two years, at LAB Research's discretion, through the subscription of newly issued common shares.
Boston Scientific Corporation reports nine-month clinical endpoint data from its ORION trial, demonstrating excellent outcomes for the Company's Epic Self-Expanding Nitinol Stent System in patients with iliac artery disease, a form of peripheral artery disease associated with severe leg pain caused by insufficient blood flow.
› Verified 6 days ago
| Entity Name | Endoscopy Center Of Central Pennsylvania |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1851363279 PECOS PAC ID: 0143279174 Enrollment ID: O20050118000287 |
News Archive
The American Association for Cancer Research (AACR) released findings today from one of the largest studies to date on passive smoking and breast cancer in women conducted by the Northern California Cancer Center (NCCC).
Cancer researchers at Princess Margaret Hospital (PMH) have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
Responding to continued debate over PSA screening, and today's American Cancer Society statement, the Prostate Cancer Foundation reiterated its position that PSA screening remains a valuable tool, in combination with other tools, for identifying potential prostate disease, including cancer.
LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced it has entered into an agreement providing for an Equity Line Facility (ELF) with Dutchess Opportunity Cayman Fund Ltd., a fund managed by Dutchess Capital Management, II LLC. Under the terms of the ELF, Dutchess has committed to provide up to $10 million of capital during the next two years, at LAB Research's discretion, through the subscription of newly issued common shares.
Boston Scientific Corporation reports nine-month clinical endpoint data from its ORION trial, demonstrating excellent outcomes for the Company's Epic Self-Expanding Nitinol Stent System in patients with iliac artery disease, a form of peripheral artery disease associated with severe leg pain caused by insufficient blood flow.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Frank Werkman, MD 1421 Fishburn Rd, Hershey, PA 17033-9795 Ph: (717) 533-2224 | Dr Robert Frank Werkman, MD 1421 Fishburn Rd, Hershey, PA 17033-9795 Ph: (717) 533-2224 |
News Archive
The American Association for Cancer Research (AACR) released findings today from one of the largest studies to date on passive smoking and breast cancer in women conducted by the Northern California Cancer Center (NCCC).
Cancer researchers at Princess Margaret Hospital (PMH) have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
Responding to continued debate over PSA screening, and today's American Cancer Society statement, the Prostate Cancer Foundation reiterated its position that PSA screening remains a valuable tool, in combination with other tools, for identifying potential prostate disease, including cancer.
LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced it has entered into an agreement providing for an Equity Line Facility (ELF) with Dutchess Opportunity Cayman Fund Ltd., a fund managed by Dutchess Capital Management, II LLC. Under the terms of the ELF, Dutchess has committed to provide up to $10 million of capital during the next two years, at LAB Research's discretion, through the subscription of newly issued common shares.
Boston Scientific Corporation reports nine-month clinical endpoint data from its ORION trial, demonstrating excellent outcomes for the Company's Epic Self-Expanding Nitinol Stent System in patients with iliac artery disease, a form of peripheral artery disease associated with severe leg pain caused by insufficient blood flow.
› Verified 6 days ago
Nicole Swallow, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, H088, Hershey, PA 17033 Phone: 717-531-1692 | |
Karen Louise Krok, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 Fax: 717-531-0061 | |
James O Ballard, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-233-4082 | |
Poonam Na Bai, Gastroenterology Medicare: Medicare Enrolled Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-6585 | |
Wilbert Hoffman Beachy Iv, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-7300 | |
Samer Nabil Muallem, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 | |
Dr. Robert David Aronoff, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 |